RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R11992 | FRAX486 | FRAX486 is a p21-activated kinase (PAK) inhibitor with IC50s of 14, 33 and 39 nM |
| R11993 | ALK inhibitor 2 | ALK inhibitor 2 is a novel and selective inhibitor for the ALK kinase. |
| R11994 | Emedastine | Emedastine is a second generation, selective histamine H1 receptor antagonist wi |
| R11995 | AD80 | AD80, a multikinase inhibitor, inhibits RET, RAF,SRCand S6K, with |
| R11996 | BTK IN-1 (SNS062 analog) | BTK IN-1 (SNS062 analog) is a potent BTK inhibitor, with an IC50& |
| R11997 | LP533401 | LP-533401 is a Tryptophan hydroxylase 1 inhibitor that regulates serot |
| R11998 | LP-533401 hydrochloride | LP-533401 hydrochloride is a tryptophan hydroxylase 1 inhibitor that r |
| R11999 | GNE3511 | GNE-3511 is a dual leucine zipper kinase (DLK) inhibitor with a K |
| R12000 | 3-(4-Amino-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one | N/A |
| R12002 | CEP-40783 | CEP-40783 is a potent, selective and orally available inhibitor of AXL |
| R12003 | LY2119620 | LY2119620 is a high-affinity muscarinic M2/M4 receptor agonist. |
| R12004 | Grazoprevir potassium salt (MK-5172 potassium salt) | Grazoprevir potassium salt (MK-5172 potassium salt) is a selective inhibitor of& |
| R12005 | UM-164 (DAS-DFGO-II) | UM-164 (DAS-DFGO-II) is a highly potent inhibitor of c-Src with a |
| R12007 | PF-06651600;PF06651600 | PF-06651600 is an orally active and selective JAK3 inhibitor with an&n |
| R12008 | Selitrectinib (LOXO-195)/CAS:1350884-56-8 | Selitrectinib (LOXO-195) is a next-generation TRK kinase inhibitor (TKI), with I |
| R12009 | Genz-682452;Ibiglustat;Venglustat; SAR402671; GZ402671) | Ibiglustat (Venglustat), a potential therapy for PD Parkinson’s disease, SRT in |
| R12010 | TA-8995 | |
| R12011 | ZINC2148701; AKOS030496792; ACN-053675 | 4-(4-Methoxyphenyl)-8-methyl-2-oxo-2H-chromen-7-yl N-{[(2-methyl-2-propanyl)oxy] |
| R12013 | CPI-444 (Synonyms: V81444; ciforadenant) | CPI-444 is a potent, oral and selective A2A receptor (A2AR) antagonist, which in |
| R12014 | CCX140 | N/A |
| R12015 | EMA 400; EMA-400; PD-126055; PD126055; PD 126055 | EMA400 is a potent and highly selective AT2R antagonist. The angiotensin II type |
| R12016 | Olodanrigan (Synonyms: EMA401; PD-126055) | Olodanrigan (EMA401; PD-126055), a highly selective, orally active, peripherally |
| R12017 | Tipifarnib S enantiomer ((S)-(-)-R-115777; IND-58359 S enantiomer) | Tipifarnib S enantiomer is the S-enantiomer of Tipifarnib. Tipifarnib is a poten |
| R12018 | PF05089771;PF-05089771;PF 05089771 | PF 05089771 is a Nav1.7 channel blocker extracted from patent WO/2010/079443 A1, |
| R12019 | MTX-211 | MTX-211 is a dual inhibitor of EGFR and PI3K, used for the treatm |
